Drug Screening Market Size Projected to Reach USD 43.01 Billion By 2033

According to Nova One Advisor, the global
drug screening market size was USD 9.18 billion in 2023, calculated at
USD 10.71 billion in 2024 and is expected to reach around USD 43.01 billion by
2033, expanding at a CAGR of 16.7% from 2024 to 2033.

Full Report is Ready | Ask here for Sample Copy@ 

The growing awareness of the benefits of drug or alcohol
screening, rising development of improved screening technology and growing
burden of drunk and driving cases are expected to drive the growth of the drug
screening market.

 The drug screening market deals with processes used to
detect the prevalence of drugs or their metabolites in biological samples such
as hair, saliva, blood, or urine. It is commonly used in various sectors such
as law enforcement agencies, sports organizations, healthcare facilities, and
workplaces to assess drug compliance with drug treatment programs. The
increasing demand for drug screening measures and increased drug and alcohol
consumption are expected to enhance the growth of the drug screening market.

In addition, increasing government initiatives such as
research funding, subsidies, and grants, rising technological advancements
accelerate the predictive power of drug screening procedures, and increasing
consumption of alcohol and drugs across the globe are further attributed to
propel the market growth. Various government initiatives to combat and monitor
substance abuse are also boosting market growth.

• For instance, in July 2022, Punjab jail authorities
  launched a major de-addiction and anti-drug-trafficking drive in the
  jails. The screening of over 8,000 prisoners in over 14 sub-jails and
  jails has found that 42% of prisoners are drug addicts. The aim behind
  this launch was to make prisons free of illegal drugs besides offering
  provisions to inmates, who are addicts, to undergo de-addiction.

Drug Screening Market Growth Factors

• Innovations in screening methods and
  automation have accelerated the drug screening process, allowing for testing
  larger compound sectors in shorter time frames.
• Growing interest from both the public and
  private sectors has led to greater funding for drug screening initiatives,
  fostering the development of new technologies and approaches.
• The rise in the shift towards
  personalized healthcare has driven the need for more efficient and
  tailored drug screening methods, spurring growth in the market.
• Regulatory agencies have implemented
  policies encouraging drug screening for rare diseases and unmet medical
  needs, providing opportunities for the market to grow globally.
• The increasing burden of chronic diseases
  worldwide has fuelled demand for novel therapeutics, driving growth in the
  drug screening market.
• Expansion into emerging markets,
  particularly in Asia-Pacific and North America, has presented new
  opportunities for growth in the drug screening market, driven by factors
  such as increasing healthcare expenditures and rising disease prevalence.

Immediate Delivery is Available | Get Full Report
Access@  

U.S. Drug Screening Market Size,
Industry Report, 2033

The U.S. drug screening market size was exhibited at USD
2.58 billion in 2023 and is projected to hit around USD 12.40 billion by 2033,
growing at a CAGR of 17.0% during the forecast period 2024 to 2033.

North America drug screening market accounted for a 40.18%
share in 2023. the market growth is attributed to the increasing presence of
major market players such as F. Hoffmann-La Roche Ltd., Thermos Fisher
Scientific, Laboratory Corporation of America Holdings Bio-Rad Laboratories,
and others. In addition, the growth of the market in the region can rapidly be
attributed to the increasing active screening programs, stringent government
regulations, and increasing prevalence of abuse. The governments are
significantly focused on controlling the consumption of harmful drugs to reduce
the cost burden related to it. The U.S. and Canada are the major countries in
the market. 

 The U.S, Drug Testing Market Trends

Due to the increasing alcohol consumption and rising
advancement in the advancement of substance screening solutions the market for
drug screening is expected to grow fastest during the forecast period in the
U.S. There are various drug screening companies in the U.S. The U.S. drug
testing companies have 20,000 drug testing and collection sites facilities that
can provide alcohol and drug testing. For instance, in May 2024, the leading
platform in at-home diagnostics and proctored testing announced an occupational
health screening management company, a partnership with i3screen, to offer
timely oral drug testing options for employers.

Europe Drug Screening Market Trends

The drug screening market in Europe was identified as a
lucrative region in this industry. The growth of the market in the region can
be attributed to the increasing substance abuse in the region and the local
presence of key market players in this region.

The drug screening market in the UK is expected to
grow over the forecast period due to the presence of well-established
healthcare infrastructure, high disposable income, and rising awareness of the
benefits of substance screening.

France drug screening market is expected to grow over
the forecast period attributed to the advancements in screening technology,
including smart, efficient, and fast solutions.

The drug screening market in Germany is expected to
grow over the forecast period due to the rising number of initiatives taken by
the government to help spread awareness. Increasing government funding for
pharmaceutical research supports the development and adoption of
substance-screening products and services.

Asia Pacific is expected to grow fastest during the
forecast period.

The rise in the developing healthcare industry, increasing
high unmet clinical needs, and increasing presence of a large target population
are expected to drive the growth of the drug screening market. They are
increasing investment in research and development activities and healthcare
infrastructure, owing to advancements in methodologies and technologies.
Furthermore, the increasing trend of outsourcing drug discovery services, the
increasing need for effective disease monitoring, and the increasing prevalence
of chronic diseases are further anticipated to drive market growth in the
region. China, India, Japan, and South Korea are the major countries in the
market.

China Drug Screening Market Trends 

China is the fastest-growing country in the healthcare
sector. The increasing focus on improving healthcare research and development
helped with the development of novel technologies and is expected to grow
fastest during the forecast period. For instance, China’s National Medical
Products Administration launched an enhancement campaign and drug safety
consolidation to estimate the foundation for drug safety. Drug regulators
investigated 153,600 cases of criminal and illegal acts including medical
devices, cosmetics, and drugs in 2022. 

The drug screening market in Japan is expected
to grow over the forecast period due to the presence of well-established
healthcare system and high adoption of advanced diagnosis tests & therapies
for effective diagnosis.

Latin America Drug Screening Market
Trends

The drug screening market in Latin America
was identified as a lucrative region in this industry. Technological
advancements and the growing awareness of the benefits of alcohol or illicit
substance-testing in the region are anticipated to fuel market growth.

Brazil drug screening market is expected to grow over the forecast period due to the
concerns related to public safety, such as substance abuse promoting violence
and impaired driving, driving the demand for drug testing solutions.

MEA Drug Screening Market Trends

The drug screening market in MEA was
identified as a lucrative region in this industry. The market in this region is
driven by the increasing consumption of illicit substances and alcohol, aided
with improvements in healthcare infrastructure.

Saudi Arabia drug screening market is expected to grow over the forecast period owing to the need
for better diagnostics and improvements in treatment options due to increasing
consumption of illicit substance and alcohol.

Most Common Types of Drug Screens

1 Urine Drug Screen

Urine drug screens are the most popular
type of drug test performed today, in part due to their low cost and simple
collection process, with around 90% of employers preferring urine tests as of 2018.The
specimen collection usually happens at a clinic or testing facility, and the
sample is then sent to a lab for processing. Depending on the type of panel
used – a 5-panel or 10-panel urine test, for example – the specimen will be
evaluated for a specific set of prescription drugs and/or illegal
substances. 

2 Saliva Drug Screen

Also known as an oral fluid drug screen,
the saliva drug test uses a less invasive collection process involving a swab
of the mouth, which may be self-performed under direct clinical supervision.
However, the drug detection period for saliva is shorter than that associated
with other specimen types. For example, the window of detection for THC in
saliva can be as short as 2-48 hours after use, whereas THC may show up in
urine, hair, and other sample types many days, weeks, or even months after
use. This offers a unique opportunity for employers to differentiate
between recent (on-the-job) substance use and prior use with oral fluid drug
testing, particularly in states where certain drugs – like cannabis – have
become legalized.

Additional substances that may be detected
on a saliva drug screen include marijuana, cocaine, opiates, alcohol,
amphetamine, methamphetamine, (including ecstasy), and PCP.

3 Blood Drug Screen

Blood testing is the least popular of the
drug screen methods, which is likely due to its more invasive nature, shorter
detection window, and higher price tag compared with other drug testing
methods. However, similar to oral fluid drug testing, blood tests can be useful
for detecting impairment and/or substance use on the job, as toxins can show up
in the blood within minutes or hours of drug use. Blood testing is also capable
of measuring the specific amount of an illegal substance in a person’s system,
helping employers or law enforcement to understand their level of impairment
and whether they may be over the recommended or legal limit of certain
substances. Some of the substances that can be detected on a blood drug test
include ethyl alcohol, amphetamines, barbiturates, benzodiazepines, cocaine and
metabolite, phencyclidine, THC, opiates, oxycodone, methadone, fentanyl,
buprenorphine, propoxyphene, meperidine, tramadol, gabapentin, and
carisoprodol.

4 Hair Drug Testing

A strand of hair acts as a timeline of a
person’s substance intake history. Someone could have used marijuana months
ago, yet through hair drug testing, the substance would still be detectable.
This is because the metabolites left behind by drug use are left in the blood,
filtered through the blood vessels in the scalp, and remain in the hair, in
detectable amounts, for about 90 days. Although not a popular form of drug
screening due to the relatively high price tag, hair drug testing can act as a
backup to urine testing in certain situations and is the only form of drug
testing that can detect some substances for months after use. The substances
that can be detected on a hair drug test include amphetamines, opiates,
cocaine, marijuana, phencyclidine, barbiturates, and expanded opiates
(oxycodone, oxymorphone, hydrocodone, hydromorphone).

Buy Now Full Report: 

Drug Screening Market Segment Insights

By product insights

Consumables led the market and accounted for 35.18% of the
global revenue in 2023 and is anticipated to grow at the fastest CAGR over the
forecast period. The consumables such as controls, specimen & temperature
test strips, blue dye tablets, calibrators, columns, reagents, and kits play a
vital role in drug screening. Consumables are broadly used to optimize
confirmation testing. For instance, in May 2024, the Ministry for Education
introduced drug testing kits in schools to fight the increasing issue of
illicit drugs among students.

The rapid testing devices segment is expected to grow
fastest during the forecast period, leading to the rising use of substance use
products such as opioids. The increasing consumption of opioids and other drugs
is expected to accelerate demand for rapid testing devices. For instance, in
October 2023, a rapid drug screening system was launched by Kerala police that
uses saliva samples and gives results in 5 minutes. Strategic initiatives such
as mergers & acquisitions, partnerships, and product launches are being
carried out by non-government and government bodies. 

 By sample type

The urine sample dominated the drug screening market and is
expected for the highest market share of 42.16% in 2023. The segment growth is
attributed to increasing urine collection for screening uses. A necessary tool
for preventing substance misuse or abuse and adhering to a prescribed regimen
is Urine Monitoring. By the Department of Transportation and Department of
Health, urine sample testing is one of the only methods approved for methods.
These samples can be used for laboratory and point-of-care diagnostic
conditions. 

Drug Screening Market By End-use Insights

Drug treatment centers led the market with a market share of
27.22% in 2023. The segment dominance can be attributed to the increasing focus
on substance abuse treatment and rehabilitation, leading to a higher demand for
drug testing services in these centers. Drug treatment centers play a crucial
role in providing comprehensive care and support to individuals struggling with
substance abuse, making drug screening an essential component of their
services. In addition, the rising prevalence of drug addiction contributes to
the segment’s share. For instance, according to the Addiction Center, about 25%
of people who use illicit substances develop an addiction, emphasizing the need
for effective monitoring and management of patients undergoing treatment,
further strengthening the segment’s share.

Pain management centers is projected to witness fastest
growth rate over the forecast period. The increasing demand for specialized
pain management services and the rising prevalence of chronic pain conditions
globally. Pain management centers play a crucial role in providing
comprehensive care and treatment for individuals suffering from various forms
of chronic pain, driving the need for efficient drug screening within these
facilities. In addition, the presence of key companies such as Boston
Scientific Corp., Medtronic, and Abbott in the market supports the growth of
this segment through strategic initiatives and technological innovations.

Immediate Delivery Available, Get Full Access@

Drug Screening Market Company Insights

Some of the major players operating in the market are Thermo
Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Quest Diagnostics
Incorporated, Abbott, and others. To gain high market size access and
prioritize maintaining high-quality standards, key players are using existing
customer bases in the region. This strategy builds trust and is useful for
brands in the market. These market players are significantly investing in
advanced infrastructure and technology which enable them to analyze and process
a large volume of samples efficiently. In addition, to strengthen their market
presence, companies undertake various strategic initiatives with other
distributors and companies.

• OraSure Technologies, Inc. and Alfa Scientific Designs,
  Inc. Are some of the developing market players in the market. These
  companies concentrate on aiming for funding support from healthcare
  organizations and government bodies that help with novel product launches.

Drug Screening Market Top Key Companies:

The following are the leading companies in
the drug screening market. These companies collectively hold the largest market
share and dictate industry trends.

• Abbott
• Quest Diagnostics Incorporated
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Siemens Healthcare AG
• Laboratory Corporation of America
  Holdings
• Alfa Scientific Designs, Inc.
• OraSure Technologies, Inc.
• Omega Laboratories, Inc.
• Drägerwerk AG & Co. KGaA
• Bio-Rad Laboratories, Inc.

Drug Screening Market Recent
Developments

• In April 2024, the largest privately held global
  provider of compliant background checks, employment monitoring, and drug
  and health screening solutions, Accurate Background announced that it is
  releasing a new mobile-first health and drug screening experience. The aim
  behind this launch was to create a better candidate experience.  
• In April 2024, an arm of Dr. Reddy’s Laboratories,
  Aurigene Pharmaceutical Services launched an AI and ML-assisted platform,
  Aurigene.AI for accelerating drug discovery projects from hit
  identification to candidate nomination.

• In December 2023, Quest Diagnostics introduced a new 88-compound test panel for
  psychoactive substances to detect substance misuse. The panel, utilizing
  advanced testing methods, aims to identify NPS in patients, address the
  evolving drug epidemic, and enhance patient care.
• In October 2023, ProciseDx Inc. received FDA clearance for therapeutic drug
  monitoring tests for adalimumab and infliximab, known as Procise ADL and
  Procise IFX, to quantify substance levels in patients with inflammatory
  bowel diseases. These tests, intended for hospital and moderate complexity
  clinical laboratories, provide quick results in 5 minutes, aiding in
  personalized dosing and optimizing care for IBD patients.
• In July 2023, Shenzhen Superbio Technology Co., LTD. received FDA clearance
  for a point-of-care instrument detecting fentanyl in human urine, and
  Carolina Liquid Chemistries Corp. partnered with Bioeasy to distribute the
  product in the US under the brand name RYAN.

Drug Screening Market Report
Segmentation

This report forecasts revenue growth at
country levels and provides an analysis of the latest industry trends in each
of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc.
has segmented the Drug Screening market.

By Product Type 

• Instruments
• Immunoassays Analyzers
• Chromatography Instruments
• Breath Analyzer
• Fuel Cell Breath Analyzer
• Semi-conductor Breath Analyzer
• Others Breath Analyzer
• Rapid Testing Devices
• Urine Testing Devices
• Drug Testing Cups
• Dip Cards
• Drug Testing Cassettes
• Oral Fluid Testing Devices
• Consumables
• Assay Kits
• Sample Collection Devices
• Calibrators & Controls
• Other Consumables
• Services and Others

By Technology 

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By End-use 

• Hospitals
• Criminal Justice & Law Enforcement Agencies
• Workplaces
• Drug Treatment Centers
• Individual Users
• Pain Management Centers
• Schools & Colleges
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Immediate Delivery Available | Buy This Premium Research 

Call: USA: +1 650 460 3308 | IND: +91 87933 22019
|Europe: +44 2080772818

Email: [email protected]

Web: